Sequent Scientific’s arm to acquire majority stake in Provet Veterinary Products

10 Sep 2014 Evaluate

Sequent Scientific’s wholly owned subsidiary, Alivira Animal Health (Alivira), has entered into an agreement to acquire 60% stake in Provet Veterinary Products, Turkey (Provet). The transaction is expected to close in October 2014, and is subject to customary closing conditions. The promoter of Provet is holding the balance 40% stake and will be part of the Management team at Alivira.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×